Apr 25, 2012 3:13 AM PDT
Not only are shares of this healthcare sector stock starting to break-out technically, fundamental indicators are also pointing to higher prices ahead. Telling the story of Neptune Technologies and Bioresources (NASDAQ: NEPT) can be a complicated and drawn...
Apr 13, 2012 3:15 AM PDT
Earlier this week, Richard Douglas, a Director at Novavax, Inc. (Nasdaq:NVAX) made a $60,500 buy of NVAX after purchasing 50,000 shares at a cost of $1.21 each. Novavax, began trading up about 4.3% on Wednesday and then closed up another 3.25% to 1.27 +0.04...
Mar 19, 2012 2:26 PM PDT
Shares of Ampio Pharmaceuticals (NASDAQ:AMPE) rocketed over 60% to a high of $4.58 on Monday after the company decided to end a study for its ophthalmology drug Optina™ ahead of schedule due to positive preliminary results and there are plenty of hints that...
Feb 24, 2012 9:58 AM PST
As larger pharmaceutical firms have shown an appetite for platform technology companies, shares for companies like PROLOR Biotech (PBTH), which possess access to platform technologies with broad-based applicability across a range of product types have been...
Feb 22, 2012 1:02 AM PST
If you stayed long Corcept Therapeutics (NASDAQ:CORT) even as others advised you against it, you should be smiling all the way to the bank.Shares of Corcept Therapeutics Inc. surged as high as $4.90 and managed to close up over 46% higher on Tuesday after the...
